[EN] 2,3-DIHYDROCYCLOPENTA[B]QUINOLINE DERIVATIVES AS MTH1 INHIBITORS FOR THE THERAPY OF CANCER<br/>[FR] DÉRIVÉS DE 2,3-DIHYDROCYCLOPENTA[B]QUINOLÉINE EN TANT QU'INHIBITEURS DE MTH1 POUR LA THÉRAPIE DU CANCER
申请人:CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH
公开号:WO2016135139A1
公开(公告)日:2016-09-01
The present invention relates to 2,3-dihydrocyclopenta[bJquinoline derivatives of formula (I) as well as pharmaceutical compositions comprising these compounds for use in the treatment or prevention of cancer, and particularly for use as inhibitors of MTH1.